Rachael Beairsto

Editor https://www.endocrinologyadvisor.com/

Rachael Beairsto is a medical editor with Haymarket Media, Inc, overseeing all things related to hormone health at Endocrinology Advisor. She holds a BS in biology from Northeastern University in Boston, Massachusetts. Prior to joining Haymarket in 2018, Rachael worked at Ogilvy in a healthcare communications role and at Sanofi in a market research group supporting the marketing of established medications within the biosurgery and renal disease spaces.

All articles by Rachael Beairsto

Diabetes

Associations Between Pemphigus and Type 1 Diabetes, Type 2 Diabetes

Rachael Beairsto

June 26, 2020

The association of pemphigus with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) is assessed.

Cardiovascular and Metabolic Disorders

Tildrakizumab Effective for Psoriasis Regardless of Metabolic Syndrome Status

Rachael Beairsto

June 25, 2020

The efficacy of tildrakizumab for the treatment of psoriasis in patients with and without metabolic syndrome was assessed.

ADA 2020

Medicaid Expansion Linked to Fewer Amputations for Minority Patients With Diabetes

Rachael Beairsto

June 16, 2020

Medicaid expansion is linked to reductions in major lower extremity amputations among racial and ethnic minority patients with diabetic foot ulcers.

ADA 2020

Lipohypertrophy Diagnosis Often Missed on Physical Examination in Patients With Diabetes

Rachael Beairsto

June 16, 2020

There is a high false-negative rate for lipohypertrophy diagnosis on physical examination in patients with type 1 or type 2 diabetes.

ADA 2020

Golimumab May Reduce Insulin Use in Newly Diagnosed Type 1 Diabetes

Rachael Beairsto

June 16, 2020

Golimumab was found to preserve β-cell function and reduce the need for exogenous insulin in young patients with type 1 diabetes.

ADA 2020

Rushed Communication Between HCPs and Black Patients Leads to Worse Glycemic Control

Rachael Beairsto

June 16, 2020

For black patients with type 2 diabetes, hurried communication with healthcare providers and lack of clear explanation can have negative effects on glycemic control.

ADA 2020

Spinal Cord Stimulation May Effectively Treat Painful Diabetic Neuropathy

Rachael Beairsto

June 16, 2020

Spinal cord stimulation may be more effective than conventional medical management alone for the treatment of painful diabetic neuropathy.

ADA 2020

Use of CGM at Diabetes Camps May Reduce Hypoglycemia in Campers

Rachael Beairsto

June 16, 2020

Use of continuous glucose monitoring significantly decreases rates of hypoglycemia among children and adolescents who attend diabetes camps.

ADA 2020

Dietary Fiber and Glycemic Control in T2D: Is There a Link?

Rachael Beairsto

June 16, 2020

Increased dietary fiber intake, whether from a high-fiber diet or supplementation, plays little role in improving glycemic control in type 2 diabetes.

Nurse having teleconference with doctor in hospital

Diabetes

Implementing CGM for Hospitalized Patients With COVID-19 and Diabetes: Insights From One Medical Center

Rachael Beairsto

May 27, 2020

In-hospital use of continuous glucose monitoring may offer improvements in glycemic control and reduced exposure to COVID-19 for healthcare professionals.

Next post in Diabetes